Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis - Concepedia

Concepedia

Publication | Open Access

Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis

DOI Full Paper Access

63

Citations

36

References

2022

Year

Daniele Focosi, Fabrizio Maggi, Scott A. McConnell, Arturo Casadevall

Antiviral Research

Remdesivir ResistanceViral EvolutionCovid-19 PandemicVirologyCovid-19 EpidemiologySars-cov-2 GenomesPublic HealthMedicineMassive UsageEpidemiologyCovid-19

References

	Year	Citations

Page 1